Ora Pescovitz, MD, CEO of the Michigan Health System, says that academic medical centers like those at the University of Michigan are among those in the lead with patient-centered medical homes (PCMHs) and accountable care organizations (ACOs).
Ora Pescovitz, MD, CEO of the Michigan Health System, says that academic medical centers like those at the University of Michigan are among those in the lead with patient-centered medical homes (PCMHs) and accountable care organizations (ACOs).
Michigan Health System participates in an ACO with 115,000 Medicare beneficiaries, as well as MiPCT, a primary care patient-centered medical home.
“I have to say we haven’t adopted those methods across our entire health system,” says Dr Pescovitz. “It remains to be seen whether these new methods will completely replace the fee-for-service, traditional methods of care delivery.”
Dr Pescovitz adds that the University of Michigan’s Center for Value-Based Insurance Design “is an innovative and creative center that has really led the nation in a concept” which could revolutionize how patients and businesses approach healthcare decision making.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
Balancing Innovation and Equity in Oncology Value-Based Care: Panel Discussions
January 27th 2025Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common theme emerged: the need to balance innovation with patient-centered, equitable, and sustainable care models.
Read More
An Argument for Outpatient Bispecific Antibody Delivery: Dr Kirollos Hanna
January 25th 2025Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.
Read More